Rational selection of antisense oligonucleotide sequences

被引:37
作者
Smith, L
Andersen, KB
Hovgaard, L
Jaroszewski, JW
机构
[1] Royal Danish Sch Pharm, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[2] Royal Danish Sch Pharm, Dept Pharmacol, DK-2100 Copenhagen, Denmark
[3] Royal Danish Sch Pharm, Dept Med Chem, DK-2100 Copenhagen, Denmark
关键词
antisense oligonucleotides; antisense selection; mRNA targeting; mRNA secondary structure; Mfold;
D O I
10.1016/S0928-0987(00)00100-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this review is to identify rational selection procedures for the identification of optimal antisense oligonucleotide sequences. The review is firstly focused on how to find optimal hybridization sites, and secondly on how to select sequences that bind to structured RNA. The methods reviewed range from the more empirical testing of large numbers of mRNA complementary sequences to the more systematic techniques, i.e. RNase H mapping, use of combinatorial arrays and prediction of secondary structure of mRNA by computational methods. Structures that bind to structured RNA, i.e. aptastrucs and tethered oligonucleotide probes, and foldback tripler-forming oligonucleotides are also discussed. Relating to selection of antisense sequences by aid of computational analysis, valuable www addresses are given along with examples of folded structures of mRNA. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 31 条
[2]   Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA [J].
Bruice, TW ;
Lima, WF .
BIOCHEMISTRY, 1997, 36 (16) :5004-5019
[3]   SELECTION OF STRUCTURE-SPECIFIC INHIBITORS OF THE HIV REV-REV RESPONSE ELEMENT COMPLEX [J].
CLOAD, ST ;
SCHEPARTZ, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (02) :437-442
[4]  
CROOKE ST, 1995, THERAPEUTIC APPL OLI, P11
[5]  
CROOKE ST, 1995, THERAPEUTIC APPL OLI, P39
[6]   SELECTION OF ANTISENSE OLIGONUCLEOTIDES ON THE BASIS OF GENOMIC FREQUENCY OF THE TARGET SEQUENCE [J].
HAN, J ;
ZHU, Z ;
HSU, CC ;
FINLEY, WH .
ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (01) :53-65
[7]   Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries [J].
Ho, SP ;
Britton, DHO ;
Stone, BA ;
Behrens, DL ;
Leffet, LM ;
Hobbs, FW ;
Miller, JA ;
Trainor, GL .
NUCLEIC ACIDS RESEARCH, 1996, 24 (10) :1901-1907
[8]   Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries [J].
Ho, SP ;
Bao, YJ ;
Lesher, T ;
Malhotra, R ;
Ma, LY ;
Fluharty, SJ ;
Sakai, RR .
NATURE BIOTECHNOLOGY, 1998, 16 (01) :59-63
[9]  
Jaroszewski J W, 1993, Antisense Res Dev, V3, P339
[10]  
JAROSZEWSKI JW, 1998, PEPTIDE PROTEIN DRUG, V43, P452